Group Therapy for Psychosocial Issues
(Group PM+ Trial)
Trial Summary
What is the purpose of this trial?
Participants are being asked to be in the study if they are the parent or legal guardian of a child (\>1 year or \<18 years old) with a rare condition. The group based psychoeducational intervention is called Rare Group Problem Management Plus. Rare Group PM Plus may help adults with practical and emotional problems. It is a group program (there will be other men or women with similar problems) It happens once a week for 5 weeks (each session lasts 90 minutes) Participants will complete assessments before they start Rare Group PM+. Participants will also complete the same assessments within a few weeks of completing Rare Group PM+. Assessments should only take one hour. Study visits are by Telemedicine. Participants will need a smart phone or tablet. If they do not have a smart phone or tablet, the study team will help with this. Participants will not receive any materials or money or medication.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on group therapy and does not involve medication changes.
What data supports the effectiveness of the treatment Group Therapy for Psychosocial Issues?
Research shows that problem-solving therapy, when combined with other management strategies, can improve outcomes for people with depression and disability. Additionally, patient-managed problem-solving groups have been effective in increasing responsible behavior in patients with chronic mental illness.12345
Is Group Problem Management Plus (PM+) safe for humans?
Group Problem Management Plus (PM+) has been used safely in various settings, including for people affected by adversity in low- and middle-income countries. It is a brief intervention delivered by non-specialists and has been evaluated for its feasibility and acceptability, indicating it is generally safe for human use.678910
What makes Group Problem Management Plus (PM+) unique compared to other treatments for psychosocial issues?
Group Problem Management Plus (PM+) is unique because it combines problem-solving strategies with group therapy, allowing participants to support each other while learning practical skills to manage their issues. This approach is cost-effective and can be particularly beneficial for those who need extended support, as it leverages the social dynamics of group settings to enhance learning and motivation.1112131415
Research Team
Maureen Lyon, PhD
Principal Investigator
Children's National Research Institute
Eligibility Criteria
This trial is for parents or guardians of children aged 1 to 17 with a rare condition. They should be able to attend weekly group sessions via telemedicine using a smartphone or tablet, which the study team can assist in providing if necessary.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Assessment
Participants complete assessments before starting the Rare Group PM+ intervention
Treatment
Participants undergo the Rare Group PM+ intervention, consisting of 5 weekly sessions
Follow-up
Participants complete assessments within 2 weeks after completing the Rare Group PM+ intervention
Treatment Details
Interventions
- Rare Group Problem Management Plus
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's National Research Institute
Lead Sponsor
Travere Therapeutics, Inc.
Industry Sponsor